Eagle Bay Advisors’s Globus Medical GMED Stock Holding History

Eagle Bay Advisors’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-9	Closed	-$483	–	995
2024 Q1	$483	Buy	+9	New	+$484	﹤0.01%	947
2023 Q1	–	Sell	-919	Closed	-$68.3K	–	953
2022 Q4	$68.3K	Buy	919 +564	+159%	+$38.4K	0.04%	314
2022 Q3	$21K	Buy	355 +73	+26%	+$4.4K	0.01%	502
2022 Q2	$15.8K	Buy	+282	New	+$18.5K	0.01%	590

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Eagle Bay Advisors's GMED Position: Q2 2024 in Review

Eagle Bay Advisors sold out of Globus Medical (GMED) in Q2 2024, closing a stake of 9 shares — an estimated $483 sold.

Eagle Bay Advisors first reported a position in GMED in Q2 2022 and held it in 4 quarters. The position peaked at $68.3K in Q4 2022. 450 funds tracked by Wall St. Rank hold GMED as of Q2 2024.

Eagle Bay Advisors reported no remaining Globus Medical position as of Q2 2024 after selling out during the quarter.
Eagle Bay Advisors sold 9 Globus Medical shares in Q2 2024, an estimated $483.
Eagle Bay Advisors first reported a position in Globus Medical in Q2 2022 and held it in 4 quarters.
Eagle Bay Advisors's Globus Medical position peaked at $68.3K in Q4 2022.
450 funds tracked by Wall St. Rank held Globus Medical as of Q2 2024.

Based on Eagle Bay Advisors's 13F filing for Q2 2024, filed 26 Jul 2024.